5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid
(中文)
| Product Name | 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid |
| CAS Number | 956317-36-5 |
| Appearance | White solid |
| Assay | 99～102% |
| Packing | 5g;10g;25g;50g;100g;1kg |
| Usage | Suvorexant |
- Description
- 在线咨询
Product Description
| Product Name | 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid |
| CAS Number | 956317-36-5 |
| Appearance | White solid |
| Assay | 99～102% |
| Packing | 5g;10g;25g;50g;100g;1kg |
| Usage | Suvorexant |
Related Products
-
Suvorexant
-
(R)-5-chloro-2-(5-Methyl-1,4-diazepan-1-yl)benzo[d]oxazole
(中文) Merck’s Sleep Drug Suvorexant (Trade Name:Belsomra) was approved on August 13, 2014 by the U.S. Food and Drug Administration (FDA) to treat insomnia.
